Analysis of Iliac Crest Biopsies From Patients Receiving Risedronate

• Status: Completed
• Trial end date: 2006-10-01
• Target enrollment: 0
• Participant gender: Female

Summary

This study analysed and reported on the study data from three similar, risedronate studies, 1996052, 2003073, and 2003096. The objective of the study was to determine the differences in the iliac crest bone histomorphometry and bone quality in postmenopausal women who had received long term therapy with risedronate.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Warner Chilcott
• Collaborator: Sanofi
• Treatments: Etidronic Acid; Risedronate Sodium; Risedronic Acid

Criteria

Inclusion Criteria:

• Completed month 36 of Study RVN-008993.

• Underwent an iliac crest bone biopsy at month 36.

Exclusion Criteria:

• Was less than 60% compliant with regard to taking study drug from the start of the study drug to month 24 of study RVN-008993.